Tougher Sanctions And Penalties Kick In For Advertising Breaches In Australia
Executive Summary
Australia has introduced new civil penalties and amended criminal offense provisions for breaches of its therapeutic product advertising rules. More reforms to the advertising regulations are expected soon.
You may also be interested in...
Australia Moves To Further Improve Advertising Framework
A review of therapeutic goods advertising reforms that were introduced in Australia in 2018 calls for further changes to support implementation and compliance.
Pharma Given Just Days To Say Whether Australian Bills Make Sense
Australian regulators are planning to introduce in Parliament in September two bills related to legislative amendments being made in response to last year’s Medicines and Medical Devices Regulation expert panel review.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.